Most people first encountered the word peptide without realizing it. GLP-1 medications like Ozempic and Mounjaro — the drugs that have reshaped the conversation around weight, metabolic health, and longevity over the past three years — are the most widely recognized. As those made headlines, people started seeking out other compounds to solve everything from everyday knee pain to gym performance. Now, a quick internet search will surface hundreds of options from just as many companies, but they are not all created equal.
To get a clearer picture of what safe, effective peptide use is, we asked Dr. Melissa Loseke, a physician and medical advisor at Joi + Blokes, to walk us through what’s real, what’s promising, and what thoughtful clinical practice actually looks like.
“Peptides are made of the same building blocks as protein, and many occur naturally within the human body,” says Dr. Loseke. “They carry specific instructions within the body that tell cells and tissues how to repair muscle, regulate hormones, reduce inflammation, or optimize metabolic function.”
Peptides first gained traction in bodybuilding and powerlifting communities, where athletes used them to accelerate recovery and build lean mass. In recent years, their potential has expanded into clinical applications across weight management, energy, longevity, immune function, and mood.
The most widely recognized peptide therapeutics are GLP-1 receptor agonists such as semaglutide (Ozempic) and tirzepatide (Mounjaro), which have demonstrated significant effects on metabolic health and cardiovascular risk, with emerging research into addiction.
As Dr. Loseke puts it, “peptide therapy, done properly, is not fringe science. It’s rapidly becoming one of the most sophisticated tools available to physicians practicing personalized, precision medicine.”
Not all peptides sit at the same point on the research curve. Ones like tesamorelin are FDA-approved for reducing visceral fat, while Thymosin Alpha-1 has strong human data for improving immunity. According to Dr. Loseke, Ipamorelin and CJC-1295 support sleep, lean mass, and recovery when monitored by a clinician.
“None of these peptides are magic bullets, despite what people may say online,” she adds. “They’re best used as part of a personalized, monitored protocol by a physician who understands the science and regulatory environment.”
Even with strong clinical evidence behind several peptides, access has gotten more complicated. While the FDA has increased enforcement of compounded peptides over the past few years, some compounds that were widely available two or three years ago now carry restricted status.
The other side of that gap is what’s filling it. Plenty of online sellers market peptides as “research chemicals” or “for research purposes only,” a legal workaround that lets the products exist outside the pharmaceutical regulatory system.
“Research-grade peptides are manufactured for laboratory use,” Dr. Loseke explains. “They aren’t produced under pharmaceutical manufacturing standards, and there’s no regulatory body requiring that these products be sterile, free of contaminants, or accurately dosed.” The greatest risk in the space, she says, is unsupervised self-sourcing of those products. The regulatory landscape is shifting fast, and what’s legally available today may not be the same in six months.
For anyone considering peptide therapy, Dr. Loseke’s read is straightforward: